Rituximab (R) + Hypercvad Alternating with R-Methotrexate/Cytarabine after 9 Years: Continued High Rate of Failure-Free Survival in Untreated Mantle Cell Lymphoma (MCL)
暂无分享，去创建一个
Michael L. Wang | H. Kantarjian | P. Mclaughlin | F. Cabanillas | A. Younes | L. Kwak | L. Fayad | J. Shah | B. Pro | Alma M Rodriguez | J. Romaguera | F. Samaniego | K. Hartig | P. Weaver | F. Hagemeister